All stock lists
Akebia Therapeutics, Inc. (AKBA)
United States · Delayed Price · Currency is USD
Healthcare
0.65+0.09 (+15.38%)
Insider Score
––Not scored
AKBA Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
AKBA Stock Insider Trading Activity
AKBA stock’s insider trading shows 1 sale on the open market for an estimated $62.18K by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Butler John P. CEO | Option exercise | 350,000 | $0.63 | $220.50K | 10.4% | 3,718,564 | Aug 6, 2026 | — | Form 4 |
| Ostrowski Erik CFO | Sell | 56,019 | $1.11 | $62.18K | 8.3% | 616,616 | Jun 29, 2026 | — | Form 4 |
| FRIESON RON Director | Award | 35,700 | — | — | 27.6% | 165,200 | Jun 17, 2026 | — | Form 4 |
| ADAMS ADRIAN Director | Award | 35,700 | — | — | 17.8% | 236,200 | Jun 17, 2026 | — | Form 4 |
| Wolf Myles Director | Award | 35,700 | — | — | 26.8% | 169,081 | Jun 17, 2026 | — | Form 4 |
| ROGERS MICHAEL W Director | Award | 35,700 | — | — | 22.1% | 197,429 | Jun 17, 2026 | — | Form 4 |
| Smith Cynthia Director | Award | 35,700 | — | — | 22.2% | 196,633 | Jun 17, 2026 | — | Form 4 |
| ZUMWALT LEANNE M Director | Award | 35,700 | — | — | 32.6% | 145,100 | Jun 17, 2026 | — | Form 4 |
| Butler John P. CEO | Buy | 69,270 | $1.25 | $86.59K | 2.1% | 3,367,064 | Mar 4, 2026 | BFirst BuyCEO BuyDilution | Form 4 |
| Malabre Richard C Other | Sell | 13,382 | $1.39 | $18.60K | 4.3% | 299,390 | Feb 2, 2026 | — | Form 4 |
| Butler John P. CEO | Sell | 46,660 | $1.39 | $64.86K | 1.3% | 3,417,189 | Feb 2, 2026 | — | Form 4 |
| Butler John P. CEO | Sell | 96,065 | $1.39 | $133.53K | 2.8% | 3,321,124 | Feb 2, 2026 | — | Form 4 |
| Butler John P. CEO | Sell | 114,891 | $1.39 | $159.70K | 3.5% | 3,206,233 | Feb 2, 2026 | — | Form 4 |
| Butler John P. CEO | Sell | 83,689 | $1.39 | $116.33K | 2.5% | 3,297,794 | Feb 2, 2026 | — | Form 4 |
| Butler John P. CEO | Award | 175,250 | $1.41 | $247.10K | 5.5% | 3,381,483 | Feb 2, 2026 | — | Form 4 |
| Burke Steven Keith Other | Sell | 21,582 | $1.39 | $30.00K | 2.1% | 994,508 | Feb 2, 2026 | — | Form 4 |
| Burke Steven Keith Other | Sell | 20,701 | $1.39 | $28.77K | 2.1% | 948,432 | Feb 2, 2026 | — | Form 4 |
| Burke Steven Keith Other | Sell | 25,375 | $1.39 | $35.27K | 2.6% | 969,133 | Feb 2, 2026 | — | Form 4 |
| Grund Nicholas Other | Sell | 31,244 | $1.39 | $43.43K | 5.3% | 561,750 | Feb 2, 2026 | — | Form 4 |
| Grund Nicholas Other | Sell | 53,585 | $1.39 | $74.48K | 8.3% | 592,994 | Feb 2, 2026 | — | Form 4 |
| Rucci Carolyn M. Other | Sell | 27,544 | $1.39 | $38.29K | 4.5% | 588,378 | Feb 2, 2026 | — | Form 4 |
| Rucci Carolyn M. Other | Sell | 25,382 | $1.39 | $35.28K | 4.0% | 615,922 | Feb 2, 2026 | — | Form 4 |
| Rucci Carolyn M. Other | Sell | 16,846 | $1.39 | $23.42K | 2.6% | 641,304 | Feb 2, 2026 | — | Form 4 |
| Ostrowski Erik CFO | Sell | 34,951 | $1.39 | $48.58K | 4.9% | 672,635 | Feb 2, 2026 | — | Form 4 |
| Malabre Richard C Other | Sell | 36,142 | $1.39 | $50.24K | 10.4% | 312,772 | Feb 2, 2026 | — | Form 4 |
| Rucci Carolyn M. Other | Award | 190,000 | — | — | 40.6% | 658,150 | Jan 30, 2026 | — | Form 4 |
| Grund Nicholas Other | Award | 204,000 | — | — | 46.1% | 646,579 | Jan 30, 2026 | — | Form 4 |
| Burke Steven Keith Other | Award | 204,000 | — | — | 25.1% | 1,016,090 | Jan 30, 2026 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Buy (P) — Open-market or private purchase
- Sell (S) — Open-market or private sale
- Award (A) — Grant or award from the company, not a purchase
- Option exercise (M) — Exercise or conversion of an exempt derivative
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.